ArticleFrontiers in public health2025
Genomic and phenotypic insights into the first imported monkeypox virus clade Ia isolate in China, 2025.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Differential pathogenesis and antiviral treatment outcomes of MPXV clade Ib and clade IIb in a BALB/c mouse model.Emerging microbes & infections · 2026Article
- A Successful Cross-Agency Model for Collaborative Response to Imported Infectious Disease: Investigation and Management of the First Confirmed Clade Ia Mpox Case in Shanghai, China.Tropical medicine and infectious disease · 2026Article
- Monkeypox Virus (MPXV) Transmission Dynamics in Neighboring Countries as a Potential Threat to Kazakhstan.Viruses · 2026Review
- Risk Assessment Method for Global Monkeypox Importation into China - May 2022-September 2025.China CDC weekly · 2026Article
- Imported Cases of Monkeypox Virus Clade Ⅰa - China, 2025.China CDC weekly · 2026Article
- The Emerging Threat of Monkeypox: An Updated Overview.Viruses · 2026Review
- Evolutionary epidemiology of the monkeypox virus in Shandong Province during the post-global outbreak era.Frontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 2022 multi-country outbreak of monkeypox virus (MPXV) sparked global health concerns, as cases emerged increasingly outside traditionally endemic regions. This outbreak, spanning 2022-2023, was primarily driven by the clade IIb strain. Subsequently, a surge of MPXV cases caused by clades Ia and Ib in the Democratic Republic of the Congo and other African countries has garnered heightened attention. Notably, clade Ib has recently been imported into China. In this study, we report the first identification and genetic characterization of a novel imported MPXV strain in China, from a patient returning from an endemic area. Whole-genome sequencing and phylogenetic analysis confirmed its close relationship to MPXV clade Ia, which has not been previously reported in China. The strain was successfully isolated using Vero-E6 cell inoculation. Compared with the reference MPXV clade I strain, the imported Ia strain exhibited substantial genomic divergence, with 67 mutations identified. Among them, 28 non-synonymous mutations were found in genes associated with host interaction and viral pathogenesis. This study highlights the critical role of genomic surveillance and rapid molecular diagnostics in monitoring MPXV transmission and evolution. The successful isolation of a clade Ia strain provides a valuable resource for future research on its pathogenicity and for the development of targeted therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.